Higher Preference for Minimally Invasive Procedures to Drive Tissue Sealing Agents and Hemostasis Market to USD 4.8 Billion by 2020

Higher Preference for Minimally Invasive Procedures to Drive Tissue Sealing Agents and Hemostasis Market to USD 4.8 Billion by 2020

Tissue Sealing Agents and Hemostasis Market 2016-2020 report estimates the global tissue sealing agents and hemostasis market to reach nearly USD 4.8 Billion in 2020, at a CAGR of 6.5% from 2016 to 2020 – iHealthcareAnalyst, Inc.

Visit the Tissue Sealing Agents and Hemostasis Market 2016-2020 report https://www.ihealthcareanalyst.com/report/tissue-sealing-agents-hemostasis-market/

The global tissue sealing agents and hemostasis market report provides market size (Revenue USD Million 2013 to 2020), market share and forecasts growth trends (CAGR%, 2016 to 2020).

An antihemorrhagic or tissue sealing agent is a substance that promotes hemostasis. Hemostasis or haemostasis is the first stage of wound healing a process which stops the bleeding. Hemostasis involves coagulation, blood changing from a liquid to a gel. Intact blood vessels are central to moderating blood’s tendency to form clots. A styptic or tissue sealing agent works by contracting tissue to seal injured blood vessels. Styptic pencils contain astringents. Antihemorrhagic agents used in medicine have various mechanisms of action such as, inhibiting fibrinolysis or promoting coagulation and vasoconstriction or promoting platelet aggregation.

The global tissue sealing agents and hemostasis segmentation is based on product types (topical hemostats, mechanical hemostats, collagen based , oxidized regenerated cellulose based , gelatin based , polysaccharide based , active hemostats – thrombin-based, flowable hemostats  – combination, adhesive and tissue sealing agents, natural tissue sealants, fibrin sealants, other natural sealants – albumin and collagen based, synthetic tissue sealants, cynoacrylate-based tissue adhesives, adhesion barrier products, other synthetic tissue sealant such as polyethylene glycol based, etc.). The global tissue sealing agents and hemostasis market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global tissue sealing agents and hemostasis market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

  1. Product Type
    • Adhesive and Tissue Sealing Agents
      • Adhesion Barrier Products
      • Natural Tissue Sealants
        • Fibrin Sealants
        • Other Natural Sealants (Albumin and Collagen based)
      • Synthetic Tissue Sealants
        • Cynoacrylate-Based Tissue Adhesives
        • Other Synthetic Tissue Sealant (Polyethylene Glycol based, etc.)
      • Topical Hemostats
        • Active Hemostats (Thrombin-Based)
        • Flowable Hemostats (Combination)
        • Mechanical Hemostats
          • Collagen based
          • Oxidized Regenerated Cellulose (ORC) based
          • Gelatin based
          • Polysaccharide based
  1. Geography (Region, Country)
    • North America (U.S., Canada)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Rest of the World
  1. Company Profiles
    • Advanced Medical Solutions Group plc
    • Baxter
    • Cohera Medical, Inc.
    • CryoLife, Inc.
    • R. Bard, Inc.
    • Johnson & Johnson Services, Inc.
    • Integra LifeSciences Corporation
    • Pfizer, Inc.

About Us

iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.

Contact Us

iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: [email protected]
Website: https://www.ihealthcareanalyst.com

2016-10-14T06:19:07+00:00 Categories: Press Releases|